$35.17
Twist Bioscience
Performance
Dividends
1W
1M
YTD
1Y
3Y
About
Synthetic DNA for Health & Sustainability #WeMakeDNA #TwistBlog #WritingTheFuture #TwistBiopharma #ScienceDoesntStop #DiversityIsInOurDNA
Twitter
Web
Share
14/36
Growth
Score
12/36
Dividend
Score
Valuation
PE Ratio
-10.98
PS Ratio
6.06
RSI
-
0
PEG Ratio
-0.17
3
PRG Ratio
0.15
PDG Ratio
0
Growth
2023
2024
2025*
2026*
3
Revenue
Revenue
*Analyst estimated growth
Fundamentals
3
Rule
of 40
67.79%
1
Gross Margin
46.7%
3
Current Ratio
4.51
Return on Assets
-32.09%
Return on Equity
-41.11%
Return on inv. Capital
-37.51%
Institutional Holder
Shares
Holders
Financials
Yealy
Quarterly
Revenue 2024 312.97M
2018
2019
2020
2021
2022
2023
2024
6
Net Income 2024 -208.73M
2018
2019
2020
2021
2022
2023
2024
6
Gross Profit 2024 133.35M
2018
2019
2020
2021
2022
2023
2024
6
Events
TWST
Twist Bioscience
in 267 days
before market open
Earnings per Share is expected with - and revenue with - .
TWST
Twist Bioscience
in 176 days
before market open
Earnings per Share is expected with - and revenue with - .
TWST
Twist Bioscience
in 99 days
before market open
Earnings per Share is expected with - and revenue with - .
About
Sector/Industry
Healthcare
Medical - Diagnostics & Research
IPO Date
31.10.2018
MaketCap
2.11B
Country
US
CEO
Emily Marine Leproust
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
Updated 18.07.2025